Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.19−0.00 (-2.01%)
Close on Nov 17, 2026Market cap $457.03KP/E –Yield –
Arcadia Biosciences cash
Cash and short-term investments held at the end of each period.
Arcadia Biosciences's cash was $4.18M at Jun 30, 2026. For fiscal 2025 it was $4.56M, up 7.6% from the year before. Over ten years it grew -21.3% a year on average. The highest annual figure on record is $50.56M in fiscal 2016.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.56M | +7.6% |
| FY2024 | Dec 31, 2024 | $4.24M | -63.6% |
| FY2023 | Dec 31, 2023 | $11.64M | -43.6% |
| FY2022 | Dec 31, 2022 | $20.64M | -28.0% |
| FY2021 | Dec 31, 2021 | $28.69M | +11.8% |
| FY2020 | Dec 31, 2020 | $25.67M | +1.3% |
| FY2019 | Dec 31, 2019 | $25.33M | +16.1% |
| FY2018 | Dec 31, 2018 | $21.82M | +67.6% |
| FY2017 | Dec 31, 2017 | $13.02M | -74.2% |
| FY2016 | Dec 31, 2016 | $50.56M | +0.6% |
| FY2015 | Dec 31, 2015 | $50.24M | +203.2% |
| FY2014 | Dec 31, 2014 | $16.57M | +484.5% |
| FY2013 | Dec 31, 2013 | $2.84M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.18M | -6.0% |
| Q1 FY2026 | Mar 31, 2026 | $3.72M | +17.8% |
| Q4 FY2025 | Dec 31, 2025 | $4.56M | +7.6% |
| Q3 FY2025 | Sep 30, 2025 | $5.89M | -10.5% |
| Q2 FY2025 | Jun 30, 2025 | $4.44M | -45.2% |
| Q1 FY2025 | Mar 31, 2025 | $3.16M | -62.8% |
| Q4 FY2024 | Dec 31, 2024 | $4.24M | -63.6% |
| Q3 FY2024 | Sep 30, 2024 | $6.58M | -58.1% |
| Q2 FY2024 | Jun 30, 2024 | $8.11M | -56.2% |
| Q1 FY2024 | Mar 31, 2024 | $8.50M | -63.0% |
| Q4 FY2023 | Dec 31, 2023 | $11.64M | -43.6% |
| Q3 FY2023 | Sep 30, 2023 | $15.70M | -30.9% |
| Q2 FY2023 | Jun 30, 2023 | $18.51M | -12.8% |
| Q1 FY2023 | Mar 31, 2023 | $23.00M | -6.3% |
| Q4 FY2022 | Dec 31, 2022 | $20.64M | -28.0% |
| Q3 FY2022 | Sep 30, 2022 | $22.72M | -36.0% |
| Q2 FY2022 | Jun 30, 2022 | $21.23M | -51.7% |
| Q1 FY2022 | Mar 31, 2022 | $24.55M | -52.7% |
| Q4 FY2021 | Dec 31, 2021 | $28.69M | +11.8% |
| Q3 FY2021 | Sep 30, 2021 | $35.53M | +248.3% |
| Q2 FY2021 | Jun 30, 2021 | $43.98M | +182.0% |
| Q1 FY2021 | Mar 31, 2021 | $51.94M | +224.2% |
| Q4 FY2020 | Dec 31, 2020 | $25.67M | +1.3% |
| Q3 FY2020 | Sep 30, 2020 | $10.20M | -67.0% |
| Q2 FY2020 | Jun 30, 2020 | $15.60M | -22.1% |
| Q1 FY2020 | Mar 31, 2020 | $16.02M | -10.0% |
| Q4 FY2019 | Dec 31, 2019 | $25.33M | +16.1% |
| Q3 FY2019 | Sep 30, 2019 | $30.90M | +25.6% |
| Q2 FY2019 | Jun 30, 2019 | $20.03M | -30.0% |
| Q1 FY2019 | Mar 31, 2019 | $17.79M | -12.9% |
| Q4 FY2018 | Dec 31, 2018 | $21.82M | +67.6% |
| Q3 FY2018 | Sep 30, 2018 | $24.60M | +56.7% |
| Q2 FY2018 | Jun 30, 2018 | $28.60M | -35.3% |
| Q1 FY2018 | Mar 31, 2018 | $20.42M | -57.9% |
| Q4 FY2017 | Dec 31, 2017 | $13.02M | -74.2% |
| Q3 FY2017 | Sep 30, 2017 | $15.70M | -70.9% |
| Q2 FY2017 | Jun 30, 2017 | $44.18M | – |
| Q1 FY2017 | Mar 31, 2017 | $48.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $50.56M | – |
| Q3 FY2016 | Sep 30, 2016 | $53.89M | – |
See a number that looks wrong?